FSH receptor binding inhibitor depresses carcinogenesis of ovarian cancer via decreasing levels of K-Ras, c-Myc and FSHR-Reference-Cited by-同舟云学术

FSH receptor binding inhibitor depresses carcinogenesis of ovarian cancer via decreasing levels of K-Ras, c-Myc and FSHR

Author:

Yang Juan¹,Gong Zhuandi²,Shen Xiaoyun³⁴,Bai Shengju¹,Bai Xiaoqiang¹,Wei Suocheng¹²

Affiliation:

1. College of Life Science and Engineering, Northwest Minzu University, Lanzhou, Gansu, P. R. China

2. Hospital of Medicine College, Northwest Minzu University, Lanzhou, Gansu, P. R. China

3. State Engineering Technology Institute for Karst Desertification Control, Guizhou Normal University, Guiyang, Guizhou, P. R. China

4. School of Life Science and Engineering, Southwest University of Science and Technology, Mianyang, Sichuan, P. R. China

Funder

Project of National Key Research and Development Program of China in the 13th Five-year plan

National Natural Science Foundation of the People’s Republic of China

Publisher

Informa UK Limited

Subject

Animal Science and Zoology,Bioengineering,Biotechnology

Link

Reference35 articles.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献